ShareHope Medicine Co., Ltd. (TPEX:8403)
22.75
-0.30 (-1.30%)
Mar 9, 2026, 1:29 PM CST
ShareHope Medicine Revenue
ShareHope Medicine had revenue of 1.11B TWD in the quarter ending September 30, 2025, a decrease of -3.69%. This brings the company's revenue in the last twelve months to 4.34B, up 1.46% year-over-year. In the year 2024, ShareHope Medicine had annual revenue of 4.33B with 11.68% growth.
Revenue (ttm)
4.34B
Revenue Growth
+1.46%
P/S Ratio
0.72
Revenue / Employee
36.81M
Employees
118
Market Cap
3.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.33B | 452.45M | 11.68% |
| Dec 31, 2023 | 3.87B | -263.75M | -6.38% |
| Dec 31, 2022 | 4.14B | 287.10M | 7.46% |
| Dec 31, 2021 | 3.85B | -248.85M | -6.07% |
| Dec 31, 2020 | 4.10B | 974.99M | 31.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 15.63B |
| Caliway Biopharmaceuticals | 34.99M |
| Heron Neutron Medical | 5.53M |
| Lotus Pharmaceutical | 18.66B |
| Intech Biopharm | 113.85M |
| ICARES Medicus | 1.09B |
| WeLeader Biomedical | 1.11B |
| SYN-TECH Chem. & Pharm. | 1.30B |